R Kumashiro
Overview
Explore the profile of R Kumashiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagao Y, Tanaka K, Kobayashi K, Kumashiro R, Sata M
Int J Mol Med
. 2004 Jan;
13(2):257-65.
PMID: 14719132
A mass screening in 1990 of H town in Japan demonstrated a high prevalence of hepatitis C virus (HCV) infection in our previous studies. The purpose of the present study...
2.
Nagao Y, Tsubone K, Kimura R, Hanada S, Kumashiro R, Ueno T, et al.
Int J Mol Med
. 2002 Feb;
9(3):293-7.
PMID: 11836636
Hepatitis C virus (HCV) has been linked to extrahepatic manifestations such as oral lichen planus (OLP). In addition, anticardiolipin antibodies (aCL) and cryoglobulin have been demonstrated in chronic hepatitis C....
3.
Torimura T, Ueno T, Kin M, Harad R, Nakamura T, Sakamoto M, et al.
J Hepatol
. 2001 Oct;
35(2):245-53.
PMID: 11580147
Background/aims: In hepatocellular carcinoma, laminin deposition to type IV collagen along the sinusoids is observed with the development of arterial network, coinciding with intrahepatic metastasis. We investigated the influence of...
4.
Ueno T, Ide T, Hashimoto O, Uchimura Y, Torimura T, Kumashiro R, et al.
Hepatogastroenterology
. 2001 Aug;
48(40):1124-8.
PMID: 11490815
Background/aims: We investigated the clinical application of serum fibrosis markers in a long-term follow-up of patients with chronic hepatitis C treated with interferon-alpha. Methodology: This study included 52 patients treated...
5.
Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, et al.
Hepatol Res
. 2001 Jul;
21(1):76-84.
PMID: 11470630
Changes in the HBV DNA level during the treatment of patients with chronic hepatitis B with lamivudine were investigated by the transcription-mediated amplification (TMA) assay. Twenty-four patients treated with lamivudine...
6.
Torimura T, Ueno T, Kin M, Harada R, Nakamura T, Kawaguchi T, et al.
Hepatology
. 2001 Jun;
34(1):62-71.
PMID: 11431735
Autocrine motility factor/phosphohexose isomerase (AMF/PHI) is a cytokine that is linked to tumor invasion and metastasis. In hepatocellular carcinoma (HCC) tissues, hepatoma cells produce AMF/PHI and its receptor, Mr 78,000...
7.
Danno M, Shiroto H, Kunii Y, ISHIBIKI K, Yamamura Y, Sakamoto Y, et al.
Gan To Kagaku Ryoho
. 2001 Mar;
28(2):195-203.
PMID: 11242646
The purpose of this study was to investigate the correlation between efficacy and dose intensity of postoperative adjuvant chemotherapy with MMC and UFT. A total of 1,410 patients from 180...
8.
Ogata R, Majima Y, Tateishi Y, Kuromatsu R, SHIMAUCHI Y, Torimyra T, et al.
Oncol Rep
. 2000 Oct;
7(6):1293-8.
PMID: 11032932
Ultrasonography (US) and computed tomography (CT) are the most effective screening methodologies for hepatocellular carcinoma (HCC). In our US screening, 20% of small HCC nodules less than 20 mm in...
9.
Murashima S, Kumashiro R, Ide T, Miyajima I, Hino T, Koga Y, et al.
J Med Virol
. 2000 Sep;
62(2):185-90.
PMID: 11002247
Interferon (IFN) is widely used for patients with hepatitis C. Less than half of treated patients respond to IFN therapy, however, and increased resistance to IFN is particularly observed in...
10.
Harada M, Sakisaka S, Kawaguchi T, Kimura R, Taniguchi E, Koga H, et al.
Biochem Biophys Res Commun
. 2000 Sep;
275(3):871-6.
PMID: 10973814
Wilson's disease is a genetic disorder characterized by the accumulation of copper in the body due to a defect of biliary copper excretion. However, the mechanism of biliary copper excretion...